nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—POMC—rheumatoid arthritis	0.568	1	CbGaD
Loperamide—ABCB1—Methylprednisolone—rheumatoid arthritis	0.0183	0.0791	CbGbCtD
Loperamide—CYP2C8—Hydrocortisone—rheumatoid arthritis	0.0164	0.0711	CbGbCtD
Loperamide—CYP2C8—Cyclosporine—rheumatoid arthritis	0.0155	0.0671	CbGbCtD
Loperamide—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0149	0.0643	CbGbCtD
Loperamide—CYP2B6—Dexamethasone—rheumatoid arthritis	0.0135	0.0584	CbGbCtD
Loperamide—ABCB1—Betamethasone—rheumatoid arthritis	0.0119	0.0514	CbGbCtD
Loperamide—ABCB1—Prednisolone—rheumatoid arthritis	0.0117	0.0507	CbGbCtD
Loperamide—ABCB1—Hydrocortisone—rheumatoid arthritis	0.0111	0.0481	CbGbCtD
Loperamide—ABCB1—Prednisone—rheumatoid arthritis	0.0111	0.0479	CbGbCtD
Loperamide—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.011	0.0474	CbGbCtD
Loperamide—ABCB1—Cyclosporine—rheumatoid arthritis	0.0105	0.0454	CbGbCtD
Loperamide—CYP2C8—Dexamethasone—rheumatoid arthritis	0.0102	0.0442	CbGbCtD
Loperamide—CYP2D6—Cyclosporine—rheumatoid arthritis	0.0099	0.0428	CbGbCtD
Loperamide—CYP3A4—Triamcinolone—rheumatoid arthritis	0.00831	0.0359	CbGbCtD
Loperamide—CYP3A4—Betamethasone—rheumatoid arthritis	0.00713	0.0308	CbGbCtD
Loperamide—CYP3A4—Prednisolone—rheumatoid arthritis	0.00703	0.0304	CbGbCtD
Loperamide—ABCB1—Dexamethasone—rheumatoid arthritis	0.00692	0.0299	CbGbCtD
Loperamide—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.00667	0.0288	CbGbCtD
Loperamide—CYP3A4—Prednisone—rheumatoid arthritis	0.00664	0.0287	CbGbCtD
Loperamide—CYP2D6—Dexamethasone—rheumatoid arthritis	0.00652	0.0282	CbGbCtD
Loperamide—CYP3A4—Cyclosporine—rheumatoid arthritis	0.0063	0.0272	CbGbCtD
Loperamide—ABCB1—Methotrexate—rheumatoid arthritis	0.00556	0.024	CbGbCtD
Loperamide—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00415	0.0179	CbGbCtD
Loperamide—Dermatitis—Penicillamine—rheumatoid arthritis	0.000316	0.00451	CcSEcCtD
Loperamide—Abdominal pain upper—Hydrocortisone—rheumatoid arthritis	0.000315	0.00448	CcSEcCtD
Loperamide—Immune system disorder—Leflunomide—rheumatoid arthritis	0.000314	0.00447	CcSEcCtD
Loperamide—Dermatitis bullous—Betamethasone—rheumatoid arthritis	0.000308	0.00439	CcSEcCtD
Loperamide—Dermatitis bullous—Dexamethasone—rheumatoid arthritis	0.000308	0.00439	CcSEcCtD
Loperamide—Abdominal distension—Prednisolone—rheumatoid arthritis	0.000307	0.00437	CcSEcCtD
Loperamide—Anaphylactoid reaction—Dexamethasone—rheumatoid arthritis	0.000304	0.00433	CcSEcCtD
Loperamide—Anaphylactoid reaction—Betamethasone—rheumatoid arthritis	0.000304	0.00433	CcSEcCtD
Loperamide—Abdominal distension—Hydrocortisone—rheumatoid arthritis	0.0003	0.00427	CcSEcCtD
Loperamide—Nausea—Penicillamine—rheumatoid arthritis	0.000298	0.00425	CcSEcCtD
Loperamide—Flatulence—Leflunomide—rheumatoid arthritis	0.000298	0.00425	CcSEcCtD
Loperamide—Depressed level of consciousness—Methotrexate—rheumatoid arthritis	0.000285	0.00406	CcSEcCtD
Loperamide—Abdominal distension—Triamcinolone—rheumatoid arthritis	0.000282	0.00402	CcSEcCtD
Loperamide—Abdominal distension—Methylprednisolone—rheumatoid arthritis	0.000282	0.00401	CcSEcCtD
Loperamide—Angioedema—Leflunomide—rheumatoid arthritis	0.000276	0.00394	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—rheumatoid arthritis	0.000271	0.00386	CcSEcCtD
Loperamide—Discomfort—Azathioprine—rheumatoid arthritis	0.000269	0.00384	CcSEcCtD
Loperamide—Urinary tract disorder—Cyclosporine—rheumatoid arthritis	0.000265	0.00377	CcSEcCtD
Loperamide—Urethral disorder—Cyclosporine—rheumatoid arthritis	0.000263	0.00375	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—rheumatoid arthritis	0.000256	0.00364	CcSEcCtD
Loperamide—Discomfort—Leflunomide—rheumatoid arthritis	0.000254	0.00362	CcSEcCtD
Loperamide—Skin disorder—Azathioprine—rheumatoid arthritis	0.000254	0.00362	CcSEcCtD
Loperamide—Dry mouth—Leflunomide—rheumatoid arthritis	0.000252	0.00359	CcSEcCtD
Loperamide—Anaphylactic shock—Leflunomide—rheumatoid arthritis	0.000247	0.00352	CcSEcCtD
Loperamide—Nervous system disorder—Leflunomide—rheumatoid arthritis	0.000242	0.00345	CcSEcCtD
Loperamide—Skin disorder—Leflunomide—rheumatoid arthritis	0.00024	0.00342	CcSEcCtD
Loperamide—POMC—connective tissue—rheumatoid arthritis	0.00024	0.126	CbGeAlD
Loperamide—Flatulence—Cyclosporine—rheumatoid arthritis	0.00023	0.00328	CcSEcCtD
Loperamide—Gastrointestinal disorder—Azathioprine—rheumatoid arthritis	0.000226	0.00322	CcSEcCtD
Loperamide—Abdominal distension—Prednisone—rheumatoid arthritis	0.000223	0.00318	CcSEcCtD
Loperamide—Anaphylactoid reaction—Methotrexate—rheumatoid arthritis	0.000221	0.00315	CcSEcCtD
Loperamide—Dyspepsia—Leflunomide—rheumatoid arthritis	0.000217	0.0031	CcSEcCtD
Loperamide—Immune system disorder—Hydrocortisone—rheumatoid arthritis	0.000215	0.00307	CcSEcCtD
Loperamide—Gastrointestinal pain—Azathioprine—rheumatoid arthritis	0.000214	0.00305	CcSEcCtD
Loperamide—Angioedema—Cyclosporine—rheumatoid arthritis	0.000213	0.00304	CcSEcCtD
Loperamide—Gastrointestinal disorder—Leflunomide—rheumatoid arthritis	0.000213	0.00304	CcSEcCtD
Loperamide—Fatigue—Leflunomide—rheumatoid arthritis	0.000213	0.00303	CcSEcCtD
Loperamide—Constipation—Leflunomide—rheumatoid arthritis	0.000211	0.00301	CcSEcCtD
Loperamide—Abdominal pain—Azathioprine—rheumatoid arthritis	0.000207	0.00294	CcSEcCtD
Loperamide—Immune system disorder—Methylprednisolone—rheumatoid arthritis	0.000202	0.00288	CcSEcCtD
Loperamide—Gastrointestinal pain—Leflunomide—rheumatoid arthritis	0.000202	0.00288	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—rheumatoid arthritis	0.000197	0.00281	CcSEcCtD
Loperamide—Discomfort—Cyclosporine—rheumatoid arthritis	0.000196	0.0028	CcSEcCtD
Loperamide—Urticaria—Leflunomide—rheumatoid arthritis	0.000196	0.00279	CcSEcCtD
Loperamide—Abdominal pain—Leflunomide—rheumatoid arthritis	0.000195	0.00278	CcSEcCtD
Loperamide—Dry mouth—Cyclosporine—rheumatoid arthritis	0.000194	0.00277	CcSEcCtD
Loperamide—Angioedema—Prednisolone—rheumatoid arthritis	0.000194	0.00277	CcSEcCtD
Loperamide—Toxic epidermal necrolysis—Methotrexate—rheumatoid arthritis	0.000193	0.00275	CcSEcCtD
Loperamide—Hypersensitivity—Azathioprine—rheumatoid arthritis	0.000193	0.00274	CcSEcCtD
Loperamide—Anaphylactic shock—Cyclosporine—rheumatoid arthritis	0.000191	0.00271	CcSEcCtD
Loperamide—Angioedema—Hydrocortisone—rheumatoid arthritis	0.00019	0.0027	CcSEcCtD
Loperamide—Nervous system disorder—Cyclosporine—rheumatoid arthritis	0.000187	0.00266	CcSEcCtD
Loperamide—Loss of consciousness—Prednisolone—rheumatoid arthritis	0.000187	0.00266	CcSEcCtD
Loperamide—Skin disorder—Cyclosporine—rheumatoid arthritis	0.000185	0.00264	CcSEcCtD
Loperamide—Loss of consciousness—Hydrocortisone—rheumatoid arthritis	0.000182	0.0026	CcSEcCtD
Loperamide—Hypersensitivity—Leflunomide—rheumatoid arthritis	0.000182	0.00259	CcSEcCtD
Loperamide—Diarrhoea—Azathioprine—rheumatoid arthritis	0.000179	0.00255	CcSEcCtD
Loperamide—Discomfort—Prednisolone—rheumatoid arthritis	0.000179	0.00255	CcSEcCtD
Loperamide—Angioedema—Triamcinolone—rheumatoid arthritis	0.000179	0.00254	CcSEcCtD
Loperamide—Angioedema—Methylprednisolone—rheumatoid arthritis	0.000178	0.00254	CcSEcCtD
Loperamide—Asthenia—Leflunomide—rheumatoid arthritis	0.000177	0.00252	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—rheumatoid arthritis	0.000175	0.0025	CcSEcCtD
Loperamide—POMC—lymphoid tissue—rheumatoid arthritis	0.000175	0.0921	CbGeAlD
Loperamide—Pruritus—Leflunomide—rheumatoid arthritis	0.000175	0.00249	CcSEcCtD
Loperamide—Discomfort—Hydrocortisone—rheumatoid arthritis	0.000175	0.00249	CcSEcCtD
Loperamide—Anaphylactic shock—Prednisolone—rheumatoid arthritis	0.000173	0.00247	CcSEcCtD
Loperamide—POMC—digestive system—rheumatoid arthritis	0.000173	0.0909	CbGeAlD
Loperamide—Dizziness—Azathioprine—rheumatoid arthritis	0.000173	0.00246	CcSEcCtD
Loperamide—Loss of consciousness—Triamcinolone—rheumatoid arthritis	0.000172	0.00245	CcSEcCtD
Loperamide—Loss of consciousness—Methylprednisolone—rheumatoid arthritis	0.000171	0.00244	CcSEcCtD
Loperamide—Somnolence—Cyclosporine—rheumatoid arthritis	0.000169	0.00241	CcSEcCtD
Loperamide—Anaphylactic shock—Hydrocortisone—rheumatoid arthritis	0.000169	0.00241	CcSEcCtD
Loperamide—Diarrhoea—Leflunomide—rheumatoid arthritis	0.000169	0.00241	CcSEcCtD
Loperamide—Dyspepsia—Cyclosporine—rheumatoid arthritis	0.000168	0.00239	CcSEcCtD
Loperamide—Vomiting—Azathioprine—rheumatoid arthritis	0.000166	0.00237	CcSEcCtD
Loperamide—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	0.000166	0.00237	CcSEcCtD
Loperamide—Drowsiness—Methotrexate—rheumatoid arthritis	0.000165	0.00235	CcSEcCtD
Loperamide—Rash—Azathioprine—rheumatoid arthritis	0.000165	0.00235	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	0.000165	0.00235	CcSEcCtD
Loperamide—Dermatitis—Azathioprine—rheumatoid arthritis	0.000165	0.00235	CcSEcCtD
Loperamide—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	0.000165	0.00234	CcSEcCtD
Loperamide—Skin disorder—Hydrocortisone—rheumatoid arthritis	0.000164	0.00234	CcSEcCtD
Loperamide—Discomfort—Triamcinolone—rheumatoid arthritis	0.000164	0.00234	CcSEcCtD
Loperamide—Fatigue—Cyclosporine—rheumatoid arthritis	0.000164	0.00234	CcSEcCtD
Loperamide—Discomfort—Methylprednisolone—rheumatoid arthritis	0.000164	0.00234	CcSEcCtD
Loperamide—Headache—Azathioprine—rheumatoid arthritis	0.000164	0.00233	CcSEcCtD
Loperamide—Stevens-Johnson syndrome—Methotrexate—rheumatoid arthritis	0.000164	0.00233	CcSEcCtD
Loperamide—Dizziness—Leflunomide—rheumatoid arthritis	0.000163	0.00233	CcSEcCtD
Loperamide—Constipation—Cyclosporine—rheumatoid arthritis	0.000163	0.00232	CcSEcCtD
Loperamide—Dry mouth—Triamcinolone—rheumatoid arthritis	0.000163	0.00232	CcSEcCtD
Loperamide—Angioedema—Dexamethasone—rheumatoid arthritis	0.000162	0.00231	CcSEcCtD
Loperamide—Angioedema—Betamethasone—rheumatoid arthritis	0.000162	0.00231	CcSEcCtD
Loperamide—Immune system disorder—Prednisone—rheumatoid arthritis	0.00016	0.00228	CcSEcCtD
Loperamide—Anaphylactic shock—Triamcinolone—rheumatoid arthritis	0.000159	0.00227	CcSEcCtD
Loperamide—Anaphylactic shock—Methylprednisolone—rheumatoid arthritis	0.000159	0.00227	CcSEcCtD
Loperamide—Vomiting—Leflunomide—rheumatoid arthritis	0.000157	0.00224	CcSEcCtD
Loperamide—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.000156	0.00222	CcSEcCtD
Loperamide—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	0.000156	0.00222	CcSEcCtD
Loperamide—Loss of consciousness—Dexamethasone—rheumatoid arthritis	0.000156	0.00222	CcSEcCtD
Loperamide—Loss of consciousness—Betamethasone—rheumatoid arthritis	0.000156	0.00222	CcSEcCtD
Loperamide—Rash—Leflunomide—rheumatoid arthritis	0.000156	0.00222	CcSEcCtD
Loperamide—Dermatitis—Leflunomide—rheumatoid arthritis	0.000156	0.00222	CcSEcCtD
Loperamide—Nausea—Azathioprine—rheumatoid arthritis	0.000155	0.00221	CcSEcCtD
Loperamide—Headache—Leflunomide—rheumatoid arthritis	0.000155	0.0022	CcSEcCtD
Loperamide—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.000155	0.0022	CcSEcCtD
Loperamide—Urticaria—Cyclosporine—rheumatoid arthritis	0.000151	0.00216	CcSEcCtD
Loperamide—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.000151	0.00215	CcSEcCtD
Loperamide—Discomfort—Betamethasone—rheumatoid arthritis	0.000149	0.00212	CcSEcCtD
Loperamide—Discomfort—Dexamethasone—rheumatoid arthritis	0.000149	0.00212	CcSEcCtD
Loperamide—Dyspepsia—Hydrocortisone—rheumatoid arthritis	0.000149	0.00212	CcSEcCtD
Loperamide—Nausea—Leflunomide—rheumatoid arthritis	0.000147	0.00209	CcSEcCtD
Loperamide—Urinary tract disorder—Methotrexate—rheumatoid arthritis	0.000146	0.00209	CcSEcCtD
Loperamide—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000146	0.00208	CcSEcCtD
Loperamide—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000146	0.00208	CcSEcCtD
Loperamide—Urethral disorder—Methotrexate—rheumatoid arthritis	0.000145	0.00207	CcSEcCtD
Loperamide—Anaphylactic shock—Betamethasone—rheumatoid arthritis	0.000145	0.00206	CcSEcCtD
Loperamide—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	0.000145	0.00206	CcSEcCtD
Loperamide—CALM2—exocrine gland—rheumatoid arthritis	0.000143	0.075	CbGeAlD
Loperamide—CALM1—exocrine gland—rheumatoid arthritis	0.000142	0.0747	CbGeAlD
Loperamide—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000142	0.00202	CcSEcCtD
Loperamide—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000142	0.00202	CcSEcCtD
Loperamide—Angioedema—Prednisone—rheumatoid arthritis	0.000141	0.00201	CcSEcCtD
Loperamide—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.00014	0.002	CcSEcCtD
Loperamide—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.00014	0.002	CcSEcCtD
Loperamide—Erythema multiforme—Methotrexate—rheumatoid arthritis	0.00014	0.002	CcSEcCtD
Loperamide—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.00014	0.00199	CcSEcCtD
Loperamide—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000138	0.00197	CcSEcCtD
Loperamide—Urticaria—Prednisolone—rheumatoid arthritis	0.000138	0.00196	CcSEcCtD
Loperamide—Fatigue—Triamcinolone—rheumatoid arthritis	0.000137	0.00196	CcSEcCtD
Loperamide—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000137	0.00195	CcSEcCtD
Loperamide—Asthenia—Cyclosporine—rheumatoid arthritis	0.000137	0.00195	CcSEcCtD
Loperamide—Loss of consciousness—Prednisone—rheumatoid arthritis	0.000136	0.00193	CcSEcCtD
Loperamide—Pruritus—Cyclosporine—rheumatoid arthritis	0.000135	0.00192	CcSEcCtD
Loperamide—Urticaria—Hydrocortisone—rheumatoid arthritis	0.000135	0.00192	CcSEcCtD
Loperamide—Immune system disorder—Methotrexate—rheumatoid arthritis	0.000134	0.00191	CcSEcCtD
Loperamide—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000134	0.00191	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000131	0.00186	CcSEcCtD
Loperamide—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.00013	0.00186	CcSEcCtD
Loperamide—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.00013	0.00185	CcSEcCtD
Loperamide—Discomfort—Prednisone—rheumatoid arthritis	0.00013	0.00185	CcSEcCtD
Loperamide—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000128	0.00182	CcSEcCtD
Loperamide—Dyspepsia—Dexamethasone—rheumatoid arthritis	0.000127	0.00181	CcSEcCtD
Loperamide—Dyspepsia—Betamethasone—rheumatoid arthritis	0.000127	0.00181	CcSEcCtD
Loperamide—Urticaria—Triamcinolone—rheumatoid arthritis	0.000127	0.0018	CcSEcCtD
Loperamide—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000126	0.0018	CcSEcCtD
Loperamide—Dizziness—Cyclosporine—rheumatoid arthritis	0.000126	0.00179	CcSEcCtD
Loperamide—Anaphylactic shock—Prednisone—rheumatoid arthritis	0.000126	0.00179	CcSEcCtD
Loperamide—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.000126	0.00179	CcSEcCtD
Loperamide—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000125	0.00178	CcSEcCtD
Loperamide—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000125	0.00178	CcSEcCtD
Loperamide—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000125	0.00178	CcSEcCtD
Loperamide—Fatigue—Betamethasone—rheumatoid arthritis	0.000125	0.00178	CcSEcCtD
Loperamide—Fatigue—Dexamethasone—rheumatoid arthritis	0.000125	0.00178	CcSEcCtD
Loperamide—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000124	0.00176	CcSEcCtD
Loperamide—Skin disorder—Prednisone—rheumatoid arthritis	0.000122	0.00174	CcSEcCtD
Loperamide—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000122	0.00173	CcSEcCtD
Loperamide—Vomiting—Cyclosporine—rheumatoid arthritis	0.000121	0.00173	CcSEcCtD
Loperamide—Rash—Cyclosporine—rheumatoid arthritis	0.00012	0.00171	CcSEcCtD
Loperamide—Dermatitis—Cyclosporine—rheumatoid arthritis	0.00012	0.00171	CcSEcCtD
Loperamide—Pruritus—Hydrocortisone—rheumatoid arthritis	0.00012	0.00171	CcSEcCtD
Loperamide—Headache—Cyclosporine—rheumatoid arthritis	0.000119	0.0017	CcSEcCtD
Loperamide—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000118	0.00169	CcSEcCtD
Loperamide—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000118	0.00169	CcSEcCtD
Loperamide—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000117	0.00167	CcSEcCtD
Loperamide—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000117	0.00167	CcSEcCtD
Loperamide—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.000116	0.00165	CcSEcCtD
Loperamide—Urticaria—Dexamethasone—rheumatoid arthritis	0.000115	0.00164	CcSEcCtD
Loperamide—Urticaria—Betamethasone—rheumatoid arthritis	0.000115	0.00164	CcSEcCtD
Loperamide—Dizziness—Prednisolone—rheumatoid arthritis	0.000115	0.00163	CcSEcCtD
Loperamide—Asthenia—Triamcinolone—rheumatoid arthritis	0.000114	0.00163	CcSEcCtD
Loperamide—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.000114	0.00163	CcSEcCtD
Loperamide—Abdominal pain—Betamethasone—rheumatoid arthritis	0.000114	0.00163	CcSEcCtD
Loperamide—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000114	0.00163	CcSEcCtD
Loperamide—Nausea—Cyclosporine—rheumatoid arthritis	0.000113	0.00161	CcSEcCtD
Loperamide—Pruritus—Triamcinolone—rheumatoid arthritis	0.000113	0.00161	CcSEcCtD
Loperamide—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000113	0.0016	CcSEcCtD
Loperamide—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000112	0.0016	CcSEcCtD
Loperamide—Dyspepsia—Prednisone—rheumatoid arthritis	0.000111	0.00158	CcSEcCtD
Loperamide—Rash—Prednisolone—rheumatoid arthritis	0.000109	0.00156	CcSEcCtD
Loperamide—Dermatitis—Prednisolone—rheumatoid arthritis	0.000109	0.00156	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.000109	0.00155	CcSEcCtD
Loperamide—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.000109	0.00155	CcSEcCtD
Loperamide—Fatigue—Prednisone—rheumatoid arthritis	0.000109	0.00155	CcSEcCtD
Loperamide—Headache—Prednisolone—rheumatoid arthritis	0.000109	0.00155	CcSEcCtD
Loperamide—Discomfort—Methotrexate—rheumatoid arthritis	0.000109	0.00155	CcSEcCtD
Loperamide—Constipation—Prednisone—rheumatoid arthritis	0.000108	0.00153	CcSEcCtD
Loperamide—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000108	0.00153	CcSEcCtD
Loperamide—Rash—Hydrocortisone—rheumatoid arthritis	0.000107	0.00152	CcSEcCtD
Loperamide—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000107	0.00152	CcSEcCtD
Loperamide—Headache—Hydrocortisone—rheumatoid arthritis	0.000106	0.00151	CcSEcCtD
Loperamide—Dizziness—Triamcinolone—rheumatoid arthritis	0.000105	0.0015	CcSEcCtD
Loperamide—Anaphylactic shock—Methotrexate—rheumatoid arthritis	0.000105	0.0015	CcSEcCtD
Loperamide—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000105	0.0015	CcSEcCtD
Loperamide—Asthenia—Betamethasone—rheumatoid arthritis	0.000104	0.00148	CcSEcCtD
Loperamide—Asthenia—Dexamethasone—rheumatoid arthritis	0.000104	0.00148	CcSEcCtD
Loperamide—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.000103	0.00147	CcSEcCtD
Loperamide—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.000103	0.00147	CcSEcCtD
Loperamide—Nausea—Prednisolone—rheumatoid arthritis	0.000103	0.00147	CcSEcCtD
Loperamide—Pruritus—Betamethasone—rheumatoid arthritis	0.000102	0.00146	CcSEcCtD
Loperamide—Pruritus—Dexamethasone—rheumatoid arthritis	0.000102	0.00146	CcSEcCtD
Loperamide—Skin disorder—Methotrexate—rheumatoid arthritis	0.000102	0.00146	CcSEcCtD
Loperamide—Vomiting—Triamcinolone—rheumatoid arthritis	0.000101	0.00144	CcSEcCtD
Loperamide—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000101	0.00144	CcSEcCtD
Loperamide—Nausea—Hydrocortisone—rheumatoid arthritis	0.000101	0.00143	CcSEcCtD
Loperamide—Rash—Triamcinolone—rheumatoid arthritis	0.000101	0.00143	CcSEcCtD
Loperamide—Dermatitis—Triamcinolone—rheumatoid arthritis	0.0001	0.00143	CcSEcCtD
Loperamide—Rash—Methylprednisolone—rheumatoid arthritis	0.0001	0.00143	CcSEcCtD
Loperamide—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.0001	0.00143	CcSEcCtD
Loperamide—Urticaria—Prednisone—rheumatoid arthritis	0.0001	0.00143	CcSEcCtD
Loperamide—Headache—Triamcinolone—rheumatoid arthritis	9.99e-05	0.00142	CcSEcCtD
Loperamide—Headache—Methylprednisolone—rheumatoid arthritis	9.97e-05	0.00142	CcSEcCtD
Loperamide—Abdominal pain—Prednisone—rheumatoid arthritis	9.96e-05	0.00142	CcSEcCtD
Loperamide—Diarrhoea—Betamethasone—rheumatoid arthritis	9.9e-05	0.00141	CcSEcCtD
Loperamide—Diarrhoea—Dexamethasone—rheumatoid arthritis	9.9e-05	0.00141	CcSEcCtD
Loperamide—Dizziness—Dexamethasone—rheumatoid arthritis	9.57e-05	0.00136	CcSEcCtD
Loperamide—Dizziness—Betamethasone—rheumatoid arthritis	9.57e-05	0.00136	CcSEcCtD
Loperamide—Nausea—Triamcinolone—rheumatoid arthritis	9.47e-05	0.00135	CcSEcCtD
Loperamide—CALM3—parotid gland—rheumatoid arthritis	9.47e-05	0.0498	CbGeAlD
Loperamide—Nausea—Methylprednisolone—rheumatoid arthritis	9.45e-05	0.00135	CcSEcCtD
Loperamide—Somnolence—Methotrexate—rheumatoid arthritis	9.36e-05	0.00133	CcSEcCtD
Loperamide—Hypersensitivity—Prednisone—rheumatoid arthritis	9.28e-05	0.00132	CcSEcCtD
Loperamide—Dyspepsia—Methotrexate—rheumatoid arthritis	9.27e-05	0.00132	CcSEcCtD
Loperamide—Vomiting—Dexamethasone—rheumatoid arthritis	9.2e-05	0.00131	CcSEcCtD
Loperamide—Vomiting—Betamethasone—rheumatoid arthritis	9.2e-05	0.00131	CcSEcCtD
Loperamide—Rash—Betamethasone—rheumatoid arthritis	9.12e-05	0.0013	CcSEcCtD
Loperamide—Rash—Dexamethasone—rheumatoid arthritis	9.12e-05	0.0013	CcSEcCtD
Loperamide—Dermatitis—Dexamethasone—rheumatoid arthritis	9.11e-05	0.0013	CcSEcCtD
Loperamide—Dermatitis—Betamethasone—rheumatoid arthritis	9.11e-05	0.0013	CcSEcCtD
Loperamide—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	9.09e-05	0.00129	CcSEcCtD
Loperamide—Fatigue—Methotrexate—rheumatoid arthritis	9.08e-05	0.00129	CcSEcCtD
Loperamide—CALM3—saliva-secreting gland—rheumatoid arthritis	9.07e-05	0.0477	CbGeAlD
Loperamide—Headache—Betamethasone—rheumatoid arthritis	9.06e-05	0.00129	CcSEcCtD
Loperamide—Headache—Dexamethasone—rheumatoid arthritis	9.06e-05	0.00129	CcSEcCtD
Loperamide—Asthenia—Prednisone—rheumatoid arthritis	9.04e-05	0.00129	CcSEcCtD
Loperamide—Pruritus—Prednisone—rheumatoid arthritis	8.91e-05	0.00127	CcSEcCtD
Loperamide—Diarrhoea—Prednisone—rheumatoid arthritis	8.62e-05	0.00123	CcSEcCtD
Loperamide—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	8.61e-05	0.00123	CcSEcCtD
Loperamide—Nausea—Dexamethasone—rheumatoid arthritis	8.59e-05	0.00122	CcSEcCtD
Loperamide—Nausea—Betamethasone—rheumatoid arthritis	8.59e-05	0.00122	CcSEcCtD
Loperamide—Urticaria—Methotrexate—rheumatoid arthritis	8.37e-05	0.00119	CcSEcCtD
Loperamide—Dizziness—Prednisone—rheumatoid arthritis	8.33e-05	0.00119	CcSEcCtD
Loperamide—Abdominal pain—Methotrexate—rheumatoid arthritis	8.32e-05	0.00119	CcSEcCtD
Loperamide—Vomiting—Prednisone—rheumatoid arthritis	8.01e-05	0.00114	CcSEcCtD
Loperamide—Rash—Prednisone—rheumatoid arthritis	7.94e-05	0.00113	CcSEcCtD
Loperamide—Dermatitis—Prednisone—rheumatoid arthritis	7.94e-05	0.00113	CcSEcCtD
Loperamide—Headache—Prednisone—rheumatoid arthritis	7.89e-05	0.00112	CcSEcCtD
Loperamide—Hypersensitivity—Methotrexate—rheumatoid arthritis	7.76e-05	0.00111	CcSEcCtD
Loperamide—Asthenia—Methotrexate—rheumatoid arthritis	7.56e-05	0.00108	CcSEcCtD
Loperamide—Nausea—Prednisone—rheumatoid arthritis	7.48e-05	0.00107	CcSEcCtD
Loperamide—Pruritus—Methotrexate—rheumatoid arthritis	7.45e-05	0.00106	CcSEcCtD
Loperamide—CALM2—parotid gland—rheumatoid arthritis	7.44e-05	0.0391	CbGeAlD
Loperamide—Diarrhoea—Methotrexate—rheumatoid arthritis	7.21e-05	0.00103	CcSEcCtD
Loperamide—CALM2—saliva-secreting gland—rheumatoid arthritis	7.12e-05	0.0374	CbGeAlD
Loperamide—CALM1—saliva-secreting gland—rheumatoid arthritis	7.09e-05	0.0372	CbGeAlD
Loperamide—Dizziness—Methotrexate—rheumatoid arthritis	6.96e-05	0.000992	CcSEcCtD
Loperamide—Vomiting—Methotrexate—rheumatoid arthritis	6.7e-05	0.000954	CcSEcCtD
Loperamide—Rash—Methotrexate—rheumatoid arthritis	6.64e-05	0.000946	CcSEcCtD
Loperamide—Dermatitis—Methotrexate—rheumatoid arthritis	6.63e-05	0.000945	CcSEcCtD
Loperamide—Headache—Methotrexate—rheumatoid arthritis	6.6e-05	0.00094	CcSEcCtD
Loperamide—CALM2—connective tissue—rheumatoid arthritis	6.54e-05	0.0344	CbGeAlD
Loperamide—CALM1—connective tissue—rheumatoid arthritis	6.51e-05	0.0342	CbGeAlD
Loperamide—Nausea—Methotrexate—rheumatoid arthritis	6.25e-05	0.000891	CcSEcCtD
Loperamide—CALM3—tendon—rheumatoid arthritis	5.73e-05	0.0301	CbGeAlD
Loperamide—CALM2—lymphoid tissue—rheumatoid arthritis	4.78e-05	0.0251	CbGeAlD
Loperamide—CALM1—lymphoid tissue—rheumatoid arthritis	4.76e-05	0.025	CbGeAlD
Loperamide—CALM2—digestive system—rheumatoid arthritis	4.73e-05	0.0248	CbGeAlD
Loperamide—CALM1—digestive system—rheumatoid arthritis	4.7e-05	0.0247	CbGeAlD
Loperamide—CALM2—tendon—rheumatoid arthritis	4.5e-05	0.0236	CbGeAlD
Loperamide—CALM1—tendon—rheumatoid arthritis	4.48e-05	0.0235	CbGeAlD
Loperamide—CYP2B6—lymphoid tissue—rheumatoid arthritis	3.56e-05	0.0187	CbGeAlD
Loperamide—CYP2B6—digestive system—rheumatoid arthritis	3.51e-05	0.0185	CbGeAlD
Loperamide—CYP3A4—digestive system—rheumatoid arthritis	2.65e-05	0.0139	CbGeAlD
Loperamide—CYP2D6—digestive system—rheumatoid arthritis	2.61e-05	0.0137	CbGeAlD
Loperamide—ABCB1—lymphoid tissue—rheumatoid arthritis	1.9e-05	0.00999	CbGeAlD
Loperamide—ABCB1—digestive system—rheumatoid arthritis	1.88e-05	0.00987	CbGeAlD
Loperamide—CALM1—Signaling by GPCR—POMC—rheumatoid arthritis	4.38e-06	3.4e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—ICAM1—rheumatoid arthritis	4.37e-06	3.4e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—ICAM1—rheumatoid arthritis	4.37e-06	3.4e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL6ST—rheumatoid arthritis	4.37e-06	3.4e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL6ST—rheumatoid arthritis	4.37e-06	3.4e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—CD80—rheumatoid arthritis	4.35e-06	3.38e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—STAT1—rheumatoid arthritis	4.33e-06	3.36e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—STAT1—rheumatoid arthritis	4.33e-06	3.36e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—POMC—rheumatoid arthritis	4.32e-06	3.35e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—IL2—rheumatoid arthritis	4.31e-06	3.35e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—IL6—rheumatoid arthritis	4.29e-06	3.33e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—CCL2—rheumatoid arthritis	4.28e-06	3.33e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—CCL2—rheumatoid arthritis	4.28e-06	3.33e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—IL6R—rheumatoid arthritis	4.27e-06	3.32e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—IL6R—rheumatoid arthritis	4.27e-06	3.32e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CXCL10—rheumatoid arthritis	4.27e-06	3.31e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CXCL10—rheumatoid arthritis	4.27e-06	3.31e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CCL2—rheumatoid arthritis	4.23e-06	3.28e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IL6R—rheumatoid arthritis	4.21e-06	3.27e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—CD80—rheumatoid arthritis	4.21e-06	3.27e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—CD80—rheumatoid arthritis	4.21e-06	3.27e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—IL6ST—rheumatoid arthritis	4.17e-06	3.24e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CAT—rheumatoid arthritis	4.17e-06	3.24e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—BGN—rheumatoid arthritis	4.14e-06	3.22e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—NOS2—rheumatoid arthritis	4.14e-06	3.22e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—MTHFR—rheumatoid arthritis	4.11e-06	3.19e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—MMP9—rheumatoid arthritis	4.08e-06	3.17e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—IL6ST—rheumatoid arthritis	4.04e-06	3.14e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—IL6ST—rheumatoid arthritis	4.04e-06	3.14e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—NFKB1—rheumatoid arthritis	4.03e-06	3.13e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL6R—rheumatoid arthritis	4.03e-06	3.13e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MMP3—rheumatoid arthritis	4.02e-06	3.12e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—TYK2—rheumatoid arthritis	4.02e-06	3.12e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—CD80—rheumatoid arthritis	4.02e-06	3.12e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—NOS2—rheumatoid arthritis	4.01e-06	3.11e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—NOS2—rheumatoid arthritis	4.01e-06	3.11e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—MTHFR—rheumatoid arthritis	4e-06	3.11e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—MAPK8—rheumatoid arthritis	3.97e-06	3.08e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CXCL8—rheumatoid arthritis	3.95e-06	3.07e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL6R—rheumatoid arthritis	3.9e-06	3.03e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL6R—rheumatoid arthritis	3.9e-06	3.03e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MMP3—rheumatoid arthritis	3.89e-06	3.02e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MMP3—rheumatoid arthritis	3.89e-06	3.02e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—TYK2—rheumatoid arthritis	3.89e-06	3.02e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—TYK2—rheumatoid arthritis	3.89e-06	3.02e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—CD80—rheumatoid arthritis	3.89e-06	3.02e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—CD80—rheumatoid arthritis	3.89e-06	3.02e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PTK2—rheumatoid arthritis	3.87e-06	3.01e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—MTHFR—rheumatoid arthritis	3.87e-06	3e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—MTHFR—rheumatoid arthritis	3.87e-06	3e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TYK2—rheumatoid arthritis	3.84e-06	2.98e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	3.81e-06	2.96e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CCL5—rheumatoid arthritis	3.8e-06	2.95e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—IL2—rheumatoid arthritis	3.78e-06	2.93e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—NOS3—rheumatoid arthritis	3.77e-06	2.93e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—IL6—rheumatoid arthritis	3.76e-06	2.92e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PTK2—rheumatoid arthritis	3.75e-06	2.91e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PTK2—rheumatoid arthritis	3.75e-06	2.91e-05	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—TP53—rheumatoid arthritis	3.74e-06	2.91e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CSF2—rheumatoid arthritis	3.74e-06	2.91e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—IL6R—rheumatoid arthritis	3.72e-06	2.89e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—TYK2—rheumatoid arthritis	3.67e-06	2.85e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CCL5—rheumatoid arthritis	3.67e-06	2.85e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CCL5—rheumatoid arthritis	3.67e-06	2.85e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—VEGFA—rheumatoid arthritis	3.66e-06	2.84e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CAT—rheumatoid arthritis	3.63e-06	2.82e-05	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—TP53—rheumatoid arthritis	3.62e-06	2.81e-05	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—TP53—rheumatoid arthritis	3.62e-06	2.81e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CSF2—rheumatoid arthritis	3.62e-06	2.81e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CSF2—rheumatoid arthritis	3.62e-06	2.81e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—IL6R—rheumatoid arthritis	3.6e-06	2.8e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—IL6R—rheumatoid arthritis	3.6e-06	2.8e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MMP9—rheumatoid arthritis	3.58e-06	2.78e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—TYK2—rheumatoid arthritis	3.55e-06	2.76e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—TYK2—rheumatoid arthritis	3.55e-06	2.76e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—NFKB1—rheumatoid arthritis	3.54e-06	2.75e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—SPP1—rheumatoid arthritis	3.52e-06	2.73e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—CXCL8—rheumatoid arthritis	3.5e-06	2.72e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—MTHFR—rheumatoid arthritis	3.48e-06	2.7e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MAPK8—rheumatoid arthritis	3.48e-06	2.7e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IFNG—rheumatoid arthritis	3.44e-06	2.67e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CAT—rheumatoid arthritis	3.42e-06	2.66e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CCR5—rheumatoid arthritis	3.42e-06	2.66e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—SPP1—rheumatoid arthritis	3.4e-06	2.64e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—SPP1—rheumatoid arthritis	3.4e-06	2.64e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—TYK2—rheumatoid arthritis	3.39e-06	2.63e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—CXCL8—rheumatoid arthritis	3.39e-06	2.63e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—CXCL8—rheumatoid arthritis	3.39e-06	2.63e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL2RA—rheumatoid arthritis	3.37e-06	2.62e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TGFB1—rheumatoid arthritis	3.36e-06	2.61e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—IL2—rheumatoid arthritis	3.35e-06	2.6e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—C3—rheumatoid arthritis	3.34e-06	2.6e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CXCL8—rheumatoid arthritis	3.34e-06	2.6e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—NOS3—rheumatoid arthritis	3.33e-06	2.59e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IFNG—rheumatoid arthritis	3.33e-06	2.58e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IFNG—rheumatoid arthritis	3.33e-06	2.58e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—CD4—rheumatoid arthritis	3.32e-06	2.58e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CCR5—rheumatoid arthritis	3.31e-06	2.57e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CCR5—rheumatoid arthritis	3.31e-06	2.57e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—POMC—rheumatoid arthritis	3.29e-06	2.55e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—TYK2—rheumatoid arthritis	3.28e-06	2.55e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—TYK2—rheumatoid arthritis	3.28e-06	2.55e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL2RA—rheumatoid arthritis	3.26e-06	2.53e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL2RA—rheumatoid arthritis	3.26e-06	2.53e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—IL2—rheumatoid arthritis	3.24e-06	2.51e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—IL2—rheumatoid arthritis	3.24e-06	2.51e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—C3—rheumatoid arthritis	3.23e-06	2.51e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—C3—rheumatoid arthritis	3.23e-06	2.51e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—NOS3—rheumatoid arthritis	3.22e-06	2.5e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—NOS3—rheumatoid arthritis	3.22e-06	2.5e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—CD4—rheumatoid arthritis	3.21e-06	2.5e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—CD4—rheumatoid arthritis	3.21e-06	2.5e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—VEGFA—rheumatoid arthritis	3.21e-06	2.49e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—POMC—rheumatoid arthritis	3.2e-06	2.48e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IL2—rheumatoid arthritis	3.19e-06	2.48e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—IL6—rheumatoid arthritis	3.18e-06	2.47e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—LEP—rheumatoid arthritis	3.11e-06	2.42e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	3.11e-06	2.41e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—POMC—rheumatoid arthritis	3.09e-06	2.4e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—POMC—rheumatoid arthritis	3.09e-06	2.4e-05	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—IL6—rheumatoid arthritis	3.08e-06	2.4e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL1B—rheumatoid arthritis	3.07e-06	2.38e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—CD4—rheumatoid arthritis	3.07e-06	2.38e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL2—rheumatoid arthritis	3.06e-06	2.37e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—PTGS2—rheumatoid arthritis	3.05e-06	2.37e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	3.03e-06	2.35e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MMP9—rheumatoid arthritis	3.02e-06	2.35e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—LEP—rheumatoid arthritis	3.01e-06	2.34e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—LEP—rheumatoid arthritis	3.01e-06	2.34e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—ALB—rheumatoid arthritis	3e-06	2.33e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—NFKB1—rheumatoid arthritis	2.99e-06	2.32e-05	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—IL6—rheumatoid arthritis	2.98e-06	2.32e-05	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—IL6—rheumatoid arthritis	2.98e-06	2.32e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL1B—rheumatoid arthritis	2.97e-06	2.31e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL1B—rheumatoid arthritis	2.97e-06	2.31e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—CD4—rheumatoid arthritis	2.97e-06	2.3e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—CD4—rheumatoid arthritis	2.97e-06	2.3e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL2—rheumatoid arthritis	2.96e-06	2.3e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL2—rheumatoid arthritis	2.96e-06	2.3e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TGFB1—rheumatoid arthritis	2.95e-06	2.29e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—PTGS2—rheumatoid arthritis	2.95e-06	2.29e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—PTGS2—rheumatoid arthritis	2.95e-06	2.29e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MAPK8—rheumatoid arthritis	2.94e-06	2.28e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—FN1—rheumatoid arthritis	2.93e-06	2.28e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL6ST—rheumatoid arthritis	2.92e-06	2.27e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—ALB—rheumatoid arthritis	2.91e-06	2.26e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—NOS3—rheumatoid arthritis	2.86e-06	2.23e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—NFKB1—rheumatoid arthritis	2.86e-06	2.22e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	2.86e-06	2.22e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—FN1—rheumatoid arthritis	2.84e-06	2.21e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—FN1—rheumatoid arthritis	2.84e-06	2.21e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL6ST—rheumatoid arthritis	2.83e-06	2.2e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL6ST—rheumatoid arthritis	2.83e-06	2.2e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—ALB—rheumatoid arthritis	2.82e-06	2.19e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—ALB—rheumatoid arthritis	2.82e-06	2.19e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—MAPK8—rheumatoid arthritis	2.81e-06	2.19e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CD80—rheumatoid arthritis	2.81e-06	2.19e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—NOS3—rheumatoid arthritis	2.79e-06	2.17e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—POMC—rheumatoid arthritis	2.78e-06	2.16e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—NFKB1—rheumatoid arthritis	2.77e-06	2.15e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—NFKB1—rheumatoid arthritis	2.77e-06	2.15e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TP53—rheumatoid arthritis	2.77e-06	2.15e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—MAPK8—rheumatoid arthritis	2.72e-06	2.11e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—MAPK8—rheumatoid arthritis	2.72e-06	2.11e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CD80—rheumatoid arthritis	2.72e-06	2.11e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CD80—rheumatoid arthritis	2.72e-06	2.11e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—VEGFA—rheumatoid arthritis	2.71e-06	2.11e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—NOS3—rheumatoid arthritis	2.7e-06	2.1e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—NOS3—rheumatoid arthritis	2.7e-06	2.1e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—POMC—rheumatoid arthritis	2.67e-06	2.08e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PTGS2—rheumatoid arthritis	2.62e-06	2.04e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CCL2—rheumatoid arthritis	2.62e-06	2.03e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL6R—rheumatoid arthritis	2.61e-06	2.03e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—POMC—rheumatoid arthritis	2.59e-06	2.01e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—POMC—rheumatoid arthritis	2.59e-06	2.01e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PTGS2—rheumatoid arthritis	2.55e-06	1.98e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—ALB—rheumatoid arthritis	2.54e-06	1.97e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—IL6—rheumatoid arthritis	2.53e-06	1.97e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CCL2—rheumatoid arthritis	2.53e-06	1.97e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CCL2—rheumatoid arthritis	2.53e-06	1.97e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL6R—rheumatoid arthritis	2.52e-06	1.96e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL6R—rheumatoid arthritis	2.52e-06	1.96e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TGFB1—rheumatoid arthritis	2.49e-06	1.93e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PTGS2—rheumatoid arthritis	2.47e-06	1.92e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PTGS2—rheumatoid arthritis	2.47e-06	1.92e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TP53—rheumatoid arthritis	2.43e-06	1.88e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—NOS3—rheumatoid arthritis	2.43e-06	1.88e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—POMC—rheumatoid arthritis	2.42e-06	1.88e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TYK2—rheumatoid arthritis	2.38e-06	1.84e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NOS3—rheumatoid arthritis	2.33e-06	1.81e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TYK2—rheumatoid arthritis	2.3e-06	1.78e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TYK2—rheumatoid arthritis	2.3e-06	1.78e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—POMC—rheumatoid arthritis	2.28e-06	1.77e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NOS3—rheumatoid arthritis	2.26e-06	1.75e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NOS3—rheumatoid arthritis	2.26e-06	1.75e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CAT—rheumatoid arthritis	2.24e-06	1.74e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—IL6—rheumatoid arthritis	2.22e-06	1.72e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PTGS2—rheumatoid arthritis	2.22e-06	1.72e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—ALB—rheumatoid arthritis	2.21e-06	1.72e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—TGFB1—rheumatoid arthritis	2.2e-06	1.71e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—TGFB1—rheumatoid arthritis	2.13e-06	1.65e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—TGFB1—rheumatoid arthritis	2.13e-06	1.65e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—NOS3—rheumatoid arthritis	2.11e-06	1.64e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ALB—rheumatoid arthritis	2.08e-06	1.62e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CXCL8—rheumatoid arthritis	2.07e-06	1.61e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TP53—rheumatoid arthritis	2.05e-06	1.59e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CXCL8—rheumatoid arthritis	2e-06	1.55e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CXCL8—rheumatoid arthritis	2e-06	1.55e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	1.99e-06	1.55e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL2—rheumatoid arthritis	1.98e-06	1.54e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—IL6—rheumatoid arthritis	1.97e-06	1.53e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	1.93e-06	1.5e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL2—rheumatoid arthritis	1.91e-06	1.49e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL2—rheumatoid arthritis	1.91e-06	1.49e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—IL6—rheumatoid arthritis	1.9e-06	1.48e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—IL6—rheumatoid arthritis	1.9e-06	1.48e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IL6—rheumatoid arthritis	1.88e-06	1.46e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MMP9—rheumatoid arthritis	1.87e-06	1.45e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	1.87e-06	1.45e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NFKB1—rheumatoid arthritis	1.85e-06	1.44e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	1.82e-06	1.41e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MAPK8—rheumatoid arthritis	1.82e-06	1.41e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MMP9—rheumatoid arthritis	1.81e-06	1.41e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MMP9—rheumatoid arthritis	1.81e-06	1.41e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL6—rheumatoid arthritis	1.8e-06	1.4e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NFKB1—rheumatoid arthritis	1.79e-06	1.39e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NFKB1—rheumatoid arthritis	1.79e-06	1.39e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MAPK8—rheumatoid arthritis	1.76e-06	1.37e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MAPK8—rheumatoid arthritis	1.76e-06	1.37e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL6—rheumatoid arthritis	1.74e-06	1.35e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL6—rheumatoid arthritis	1.74e-06	1.35e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—VEGFA—rheumatoid arthritis	1.68e-06	1.3e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—IL6—rheumatoid arthritis	1.66e-06	1.29e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—VEGFA—rheumatoid arthritis	1.62e-06	1.26e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—VEGFA—rheumatoid arthritis	1.62e-06	1.26e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—IL6—rheumatoid arthritis	1.6e-06	1.25e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—IL6—rheumatoid arthritis	1.6e-06	1.25e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TGFB1—rheumatoid arthritis	1.54e-06	1.2e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—POMC—rheumatoid arthritis	1.49e-06	1.16e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TGFB1—rheumatoid arthritis	1.49e-06	1.16e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.49e-06	1.16e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ALB—rheumatoid arthritis	1.36e-06	1.06e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	1.3e-06	1.01e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TP53—rheumatoid arthritis	1.27e-06	9.86e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TP53—rheumatoid arthritis	1.23e-06	9.54e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TP53—rheumatoid arthritis	1.23e-06	9.54e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	1.19e-06	9.25e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL6—rheumatoid arthritis	1.16e-06	9.02e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL6—rheumatoid arthritis	1.12e-06	8.73e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL6—rheumatoid arthritis	1.12e-06	8.73e-06	CbGpPWpGaD
